Synergy of 9-beta-D-arabinofuranosyladenine and human interferon against Herpes simplex virus, type 1.
D000225:Adenine / Q000031:analogs & derivatives / Q000494:pharmacology; D000818:Animals; D000998:Antiviral Agents / Q000494:pharmacology*; D001089:Arabinose / Q000494:pharmacology; D002460:Cell Line; D046508:Culture Techniques; D004357:Drug Synergism; D000882:Haplorhini; D006801:Humans; D007042:Hypoxanthines / Q000494:pharmacology; D007065:Idoxuridine / Q000494:pharmacology; D007372:Interferons / Q000494:pharmacology*; D007668:Kidney; D009705:Nucleosides / Q000494:pharmacology*; D018139:Simplexvirus / Q000187:drug effects*; D010948:Viral Plaque Assay
D000998:Antiviral Agents; D007042:Hypoxanthines; D009705:Nucleosides; D007372:Interferons; D001089:Arabinose; D000225:Adenine; D007065:Idoxuridine